Novo Nordisk Clinical Trial Call Center

Anaheim, California 92801

0 studies enrolling now · 2 studies all time

What they study most

Crohn's Disease, Diabetes, Diabetes Mellitus, Type 2, Inflammation

Studies at this site

• Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease — Completed
• Switching From Insulin Glargine to Insulin Degludec in Subjects With Type 2 Diabetes Mellitus (BEGIN™) — Completed